[Lipid and carbohydrate metabolism in diabetics with hypercholesteremia during long-term treatment with beta-pyridylcarbinol].
D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000378:metabolism; D050356:Lipid Metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D000432:Methanol / Q000009:adverse effects; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014665:Vasodilator Agents / Q000009:adverse effects*
D001786:Blood Glucose; D009539:Nicotinic Acids; D011725:Pyridines; D014280:Triglycerides; D014665:Vasodilator Agents; D002784:Cholesterol; D000432:Methanol
Zum Lipoid- und Kohlenhydratstoffwechsel bei Diabetikern mit Hypercholesterinämie unter Langzeitbehandlung mit Beta-Pyridylcarbinol.